Product Program year 2020 Source: CMS Open Payments

Ixinity

Drug Hemophilia B

NDC 53270-0270-5

Open in the dashboard

General payments

$54,651

99 payments

Research payments

$0

0 payments

Through program year 2020, $54,651 in general payments and $0 in research payments were reported against Ixinity (Hemophilia B).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

2 rows
Year Kind Amount Payments
2020 General $5,060 4
2019 General $49,590 95

Breakdown

Who paid General payments · program years 2019–2020
  1. Aptevo Therapeutics Inc $54,651 99 payments
Top recipients General payments · program year 2020
  1. The Childrens Hospital Of Philadelp Teaching hospital · PA $5,000 99% · 1 payment
  2. Daisy Cortes Pediatric Hematology-Oncology · Las Vegas, NV $20 <1% · 1 payment
  3. Nik Nik Abdul Rashid Pediatric Hematology-Oncology · Las Vegas, NV $20 <1% · 1 payment
  4. Amy Dao Pediatrics · Albuquerque, NM $20 <1% · 1 payment

Each share is of general payments naming this product in 2020.

Specialties paid General payments · program year 2020
  1. Pediatric Hematology-Oncology Pediatrics $40 67% · 2 practitioners
  2. Pediatrics $20 33% · 1 practitioner

Each share is of general payments naming this product to practitioners with a specialty in 2020. Each practitioner is counted under their primary specialty.

Where the money went General payments · program year 2020
  1. Pennsylvania $5,000 99% · 1 recipient
  2. Nevada $60 1% · 3 recipients

Each share is of general payments naming this product in 2020 where a state was reported.

99 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2020

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record